Ryan Bond
Corporate Officer/Principal en ACLARION, INC. .
Fortuna: 411 $ al 31/03/2024
Perfil
Ryan Bond is currently the Chief Strategy Officer at Aclarion, Inc. He previously worked as the Director-Healthcare Solutions at NuVasive, Inc. from 2014 to 2018.
Mr. Bond completed his undergraduate degree at The Ohio University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ACLARION, INC.
0.02% | 30/09/2023 | 1 250 ( 0.02% ) | 411 $ | 31/03/2024 |
Cargos activos de Ryan Bond
| Empresas | Cargo | Inicio |
|---|---|---|
| ACLARION, INC. | Corporate Officer/Principal | 15/09/2021 |
Antiguos cargos conocidos de Ryan Bond.
| Empresas | Cargo | Fin |
|---|---|---|
| NUVASIVE, INC. | Corporate Officer/Principal | 01/09/2018 |
Formación de Ryan Bond.
| The Ohio University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ACLARION, INC. | Technology Services |
| Empresas privadas | 1 |
|---|---|
NuVasive, Inc.
 NuVasive, Inc. Medical SpecialtiesHealth Technology NuVasive, Inc. engages in the development, manufacture, sale, and provision of procedural solutions for spine surgery. It offers a comprehensive portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. The company was founded by Alexis V. Lukianov on July 21, 1997 and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Ryan Bond
